Expert Meeting 2023: Navigating the latest treatment landscape of mHSPC
Pre-meeting survey

*Mandatory

3. From your clinical experience, what characteristics of patients with mHSPC would affect your discretion on treatment strategies? (You can select more than 1 answer) *

6. Disregarding the concern of cost, what would be your preferred treatment regimen for de novo high-volume mHSPC patients? *

7. Similarly, what would be your first treatment choice for patients with low-volume but high risk mHSPC? *